Health Care/Hospital

3SBio Inc. Announces Filing of Annual Report on Form 20-F

SHENYANG, China, July 2 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report o...

2007-07-02 22:00 871

International Experts Meet to Discuss Health Threats Due to Global Warming

KUALA LUMPUR, June 28 /Xinhua-PRNewswire/ -- International experts will meet here from 2 to 5 July to discuss the threat to health posed by global warming in the Asia Pacific region. With global mean temperature forecast to increase by as much as six degrees Celsius by the end of the century, ...

2007-06-28 12:10 483

Conference on Tobacco Control Treaty Urged to Adopt 100% Smoke-Free Policies as Global Health Standard

Release By Global Smokefree Partnership and Campaign for Tobacco-Free Kids WASHINGTON, June 28 /Xinhua-PRNewswire/ -- Advocates are urging governments to commit to adopting 100 percent smoke-free workplaces and public places when their representatives convene at a major global conference in...

2007-06-28 08:29 583

Skystar Bio-Pharmaceutical Integrates Production of Microbial Strains

Production Costs for Microorganisms Expected to Decline By 90% XI'AN, China, June 25 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar" or "Company"), a leading bio-pharmaceutical company in the People's Republic of China ("PRC"), today...

2007-06-25 20:30 501

The International Diabetes Federation Launches US$ 10 Million Grant Programme to Improve Diabetes Care

BRUSSELS, Belgium and CHICAGO, June 23 /Xinhua-PRNewswire/ -- The International Diabetes Federation (IDF) today called for projects that adapt science to meet the needs of people living with diabetes and to implement practical solutions for improving diabetes care and prevention worldwide. The...

2007-06-23 15:00 671

World Health Organization and Stop TB Partnership Release US$2.15 Billion Plan to Contain Drug-Resistant Tuberculosis

GENEVA, June 22 /Xinhua-PRNewswire/ -- Hundreds of thousands of cases of drug-resistant tuberculosis (TB) can be prevented and as many as 134,000 lives saved through the implementation of a two-year response plan, published/launched today by the World Health Organization (WHO) and the Stop TB ...

2007-06-22 10:23 649

China Shenghuo Pharmaceutical Holdings, Inc. Retains CCG Elite

LOS ANGELES, Calif. and KUNMING, China, June 21 /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. ("China Shenghuo," "the Company") (Amex: KUN), a leading specialty pharmaceutical company engaged in researching, developing, manufacturing and marketing Sanchi-based...

2007-06-21 21:00 778

China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2007 Financial Results

Full Year Revenues Increased 40% to $30.6 Million Full year Net Income Rose 31% to $10.9 Million SHANGHAI, China, June 21 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics", "the Company"), a leading Chinese biotechnology firm specializing in...

2007-06-21 21:00 729

China Sky One Medical Receives Grant from Harbin Government

Company Honored as Innovative Enterprise in China HARBIN, China, June 20 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced that the ...

2007-06-20 20:30 497

WHO and UNICEF Call for Renewed Commitment to Breastfeeding

MANILA, June 20 /Xinhua-PRNewswire/ -- Exclusive breastfeeding rates in East Asia and the Pacific are just 61% at four months of babies’ lives and even lower, at 35%, at six months. And yet science has established that exclusive breastfeeding for the first six months of a child’s life is the s...

2007-06-20 12:25 586

Patients Begin Enrolling in Studies to Determine if Women with BRCA 1 & 2 Positive Cancer May Receive Greater Benefit From New Treatment

- AstraZeneca Collaborates With Myriad Genetics on Phase 2 Trials ALDERLEY PARK, England, June 19 /Xinhua-PRNewswire/ -- AstraZeneca (NYSE: AZN) today announced the start of two Phase II trials for a new compound being tested to treat patients with BRCA 1 & 2 positive breast and ov...

2007-06-19 18:30 599

Skystar Bio-Pharmaceutical Signs Multiple New Product and Distribution Contracts at the 2007 China Stock Breeding and Forage Industry Expo

XI'AN, China, June 18 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar" or "the Company"), a leading bio-pharmaceutical company in the People's Republic of China ("PRC"), today announced that it signed 15 new contracts valued at appr...

2007-06-18 20:00 567

U.S. Food Scientist to Receive World's Highest Food Honor

WASHINGTON, June 19 /Xinhua-PRNewswire-USNewswire/ -- Philip E. Nelson, president of the Institute of Food Technologists in 2002 and food science professor at Purdue University, will be recognized today as the 2007 recipient of the World Food Prize in an announcement here at the U.S. Departmen...

2007-06-19 00:00 695

More Than Half of Hypertensive Patients Remain Uncontrolled and at Higher Risk of Heart Attack and Stroke - Telmisartan May Decrease This Risk

- Results From Two Large, Multinational, Practice-Based Observational Studies in Blood Pressure MILAN, Italy, June 18 /Xinhua-PRNewswire/ -- New data announced today at the Annual European Society of Hypertension (ESH) show that measuring blood pressure in a doctor's office alone...

2007-06-18 16:00 558

New Study Shows That Telmisartan Has Greater Renoprotective Potential Than Losartan in Hypertensive Patients with Type 2 Diabetes

MILAN, Italy, June 18 /Xinhua-PRNewswire/ -- Today AMADEO, one of the first studies to compare the protective potential of two angiotensin receptor blockers in hypertensive patients with diabetic nephropathy, was presented at the European Society of Hypertension, Milan. The results from this s...

2007-06-18 16:00 642

Actemra: Roche's Novel Rheumatoid Arthritis Drug Shows Substantial Benefits for Patients in OPTION Study

-- New Data Supports IL-6 Receptor Inhibition as a Key Component in Controlling Inflammation From RA BASEL, Switzerland, June 15 /Xinhua-PRNewswire/ -- Roche today announced significant results from 'OPTION'(1), the first rheumatoid arthritis multinational phase III study of Actemra (tocili...

2007-06-15 16:15 669

The Global Lung Cancer Coalition Presents the 2nd Annual Lung Cancer Journalism Awards Competition

LONDON, June 14 /Xinhua-PRNewswire/ -- The Lung Cancer Journalism Awards' mission: to raise global awareness of the leading cause of cancer-related deaths worldwide. Winners receive: -- Global showcase recognising their prize-winning work -- EUR7,000 research grant En...

2007-06-14 22:04 637

Mindray Receives FDA Approval for Two Products Targeting North American Market

SHENZHEN, China, June 14 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that it has received 510(k) clearance from the U.S...

2007-06-14 20:24 691

China Shenghuo Pharmaceutical Holdings, Inc. Announces Listing on American Stock Exchange and Closing of Public Offering

KUNMING, China, June 14 /Xinhua-PRNewswire-FirstCall/ -– China Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN) announced the listing of its common stock on the American Stock Exchange on Thursday, June 14, 2007, and the closing of a public offering of its common stock at an offering price o...

2007-06-14 21:00 736

Simcere Pharmaceutical Group to Acquire Additional 10% of Equity Interest in Shangdong Simcere Medgenn Bio-Pharmaceutical Co., Ltd.

NANJING, China, June 14 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals in China, and the manufacturer of innovative anti-cancer medication Endu, today announced that it has entered into an agreement to acqui...

2007-06-14 17:39 737
1 ... 518519520521522523524 ... 532